Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion
Background and objectives: There are several formulations of propofol available to the anesthesiologist for clinical use. The aim of this study was to analyze the physicochemical properties, pharmacodynamic effect, and pharmaceutical and clinical equivalence of the reference drug propofol as well as...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Brazilian Journal of Anesthesiology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0104001413000213 |
id |
doaj-6c89a9f6bf2d4db88e40782a02c0a4cb |
---|---|
record_format |
Article |
spelling |
doaj-6c89a9f6bf2d4db88e40782a02c0a4cb2020-11-24T22:08:59ZengElsevierBrazilian Journal of Anesthesiology0104-00142013-01-016315965Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled InfusionRicardo Francisco Simoni0Luiz Eduardo de Paula Gomes Miziara1Luis Otávio Esteves2João Gilberto Ribeiro D’Castro3Carlos Alberto Morales, Jr.4Carlos Eduardo Esqueapatti Sandrin5Thaís Costa Contente6Diogo Oliveira-Silva7TSA; MD; Co-responsible for Centro de Ensino e Treinamento (CET) from Sociedade Brasileira de Anestesiologia (SBA), Instituto Penido Burnier and Centro Médico de Campinas; Corresponding author. Instituto Penido Burnier e Centro Médico de Campinas Avenida Andrade Neves, 611 13013-161, Campinas, SP, Brazil.Anesthesiologist, Hospital Santa Sofia and Centro Médico de CampinasTSA; Co-responsible for CET-SBA, Instituto Penido Burnier and Centro Médico de CampinasME3; CET-SBA Instituto Penido Burnier and Centro Médico de CampinasME3; CET-SBA Instituto Penido Burnier and Centro Médico de CampinasME3; CET-SBA Instituto Penido Burnier and Centro Médico de CampinasPhD; Researcher at Faculdade de Ciências Farmacêuticas, Universidade de São PauloPhD; Associate Professor at Universidade Federal de São Paulo (Unifesp), Campus DiademaBackground and objectives: There are several formulations of propofol available to the anesthesiologist for clinical use. The aim of this study was to analyze the physicochemical properties, pharmacodynamic effect, and pharmaceutical and clinical equivalence of the reference drug propofol as well as a similar formulation. Method: Sixteen volunteers were enrolled in this randomized, double-blind, and paired study of Diprivan® and Propovan® formulations. Formulations were given as target-controlled infusion with target concentration of 3.0 μg.mL-1 for 15 minutes. Variables studied were the area under the curve (AUC) of the bispectral index (BIS) graph regarding time, minimum BIS reached and time to reach it, and recovery time. The two formulations were sent to analysis of particle size of lipid emulsion, surface potential, and active principle quantification. Results: There was no difference between the formulations when comparing AUC, minimum BIS reached and time to reach it. The similar formulation recovery time was lower compared to the reference formulation (eight and 10 min, respectively, p = 0.014). Mean particle size of lipid emulsion, surface potential, and active ingredient quantification were similar for both formulations. Conclusion: There was no clinically significant difference between the use of propofol, reference Diprivan®, and the similar Propovan® during infusion. However, the recovery time was longer with the reference drug. Although analysis of both formulations studied show similar results regarding its physicochemical characterization, further studies should be conducted to justify this difference. Keywords: Anesthesia, Intravenous, Consciousness Monitors, Pharmacology, Clinical, Propofolhttp://www.sciencedirect.com/science/article/pii/S0104001413000213 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ricardo Francisco Simoni Luiz Eduardo de Paula Gomes Miziara Luis Otávio Esteves João Gilberto Ribeiro D’Castro Carlos Alberto Morales, Jr. Carlos Eduardo Esqueapatti Sandrin Thaís Costa Contente Diogo Oliveira-Silva |
spellingShingle |
Ricardo Francisco Simoni Luiz Eduardo de Paula Gomes Miziara Luis Otávio Esteves João Gilberto Ribeiro D’Castro Carlos Alberto Morales, Jr. Carlos Eduardo Esqueapatti Sandrin Thaís Costa Contente Diogo Oliveira-Silva Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion Brazilian Journal of Anesthesiology |
author_facet |
Ricardo Francisco Simoni Luiz Eduardo de Paula Gomes Miziara Luis Otávio Esteves João Gilberto Ribeiro D’Castro Carlos Alberto Morales, Jr. Carlos Eduardo Esqueapatti Sandrin Thaís Costa Contente Diogo Oliveira-Silva |
author_sort |
Ricardo Francisco Simoni |
title |
Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion |
title_short |
Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion |
title_full |
Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion |
title_fullStr |
Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion |
title_full_unstemmed |
Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion |
title_sort |
pharmacodynamic evaluation and physical/chemical analysis of two formulations of propofol used in target-controlled infusion |
publisher |
Elsevier |
series |
Brazilian Journal of Anesthesiology |
issn |
0104-0014 |
publishDate |
2013-01-01 |
description |
Background and objectives: There are several formulations of propofol available to the anesthesiologist for clinical use. The aim of this study was to analyze the physicochemical properties, pharmacodynamic effect, and pharmaceutical and clinical equivalence of the reference drug propofol as well as a similar formulation. Method: Sixteen volunteers were enrolled in this randomized, double-blind, and paired study of Diprivan® and Propovan® formulations. Formulations were given as target-controlled infusion with target concentration of 3.0 μg.mL-1 for 15 minutes. Variables studied were the area under the curve (AUC) of the bispectral index (BIS) graph regarding time, minimum BIS reached and time to reach it, and recovery time. The two formulations were sent to analysis of particle size of lipid emulsion, surface potential, and active principle quantification. Results: There was no difference between the formulations when comparing AUC, minimum BIS reached and time to reach it. The similar formulation recovery time was lower compared to the reference formulation (eight and 10 min, respectively, p = 0.014). Mean particle size of lipid emulsion, surface potential, and active ingredient quantification were similar for both formulations. Conclusion: There was no clinically significant difference between the use of propofol, reference Diprivan®, and the similar Propovan® during infusion. However, the recovery time was longer with the reference drug. Although analysis of both formulations studied show similar results regarding its physicochemical characterization, further studies should be conducted to justify this difference. Keywords: Anesthesia, Intravenous, Consciousness Monitors, Pharmacology, Clinical, Propofol |
url |
http://www.sciencedirect.com/science/article/pii/S0104001413000213 |
work_keys_str_mv |
AT ricardofranciscosimoni pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion AT luizeduardodepaulagomesmiziara pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion AT luisotavioesteves pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion AT joaogilbertoribeirodcastro pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion AT carlosalbertomoralesjr pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion AT carloseduardoesqueapattisandrin pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion AT thaiscostacontente pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion AT diogooliveirasilva pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion |
_version_ |
1725813584861069312 |